Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling

American Journal of Respiratory and Critical Care Medicine

Volumn 175, Issue 12, 2007, Pages 1280-1289

  Taraseviciene Stewart, Laimute ^a,b   Nicolls, Mark R ^a   Kraskauskas, Donatas ^a   Scerbavicius, Robertas ^a   Burns, Nana ^a   Cool, Carlyne ^a   Wood, Kathy ^a   Parr, Jane E ^a   Boackle, Susan A ^a   Voelkel, Norbert F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Division of Pulmonary Sciences and Critical Care Medicine   (United States)

Author keywords

Apoptosis; Proliferation; Pulmonary hypertension; T cells

Indexed keywords

INTERLEUKIN 4; SEMAXANIB; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIOLE; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; LUNG ARTERY PRESSURE; LUNG PARENCHYMA; MACROPHAGE; MALE; MAST CELL; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR REMODELING; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANGIOGENESIS INHIBITORS; ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HOMEOSTASIS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; INDOLES; INJECTIONS, SUBCUTANEOUS; MALE; PYRROLES; RATS; RATS, NUDE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; T-LYMPHOCYTES;

EID: 34250205557     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200608-1189OC     Document Type: Article

References (53)

1. Fagan KA, Badesch DB. Pulmonary hypertension associated with connective tissue disease. Prog Cardiovasc Dis 2002;45:225-234.
2. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329-337.
3. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997;151:1517-1522.
4. Kemeny L, Kiss M, Gyulai R, Kenderessy AS, Adam E, Nagy F, Dobozy A. Human herpesvirus 8 in classic Kaposi sarcoma. Acta Microbiol Immunol Hung 1996;43:391-395.
5. Onji M, Doi Y, Miyaoka H, Masumoto T, Horiike N, Ohta Y. Serum levels of soluble CD4 and CD8 in patients with chronic viral hepatitis. Hepatogastroenterology 1994;41:377-379.
6. Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K Jr. Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin Immunol Immunopathol 1990;56:259-270.
7. Ingegnoli F, Trabattoni D, Saresella M, Fantini F, Clerici M. Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis. Clin Immunol 2003;108:21-28.
8. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003;21:273-276.
9. Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004;59:198-202.
10. Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H. Pulmonary hypertension after splenectomy? Ann Intern Med 1999;130:506-509.
11. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994;144:275-285.
12. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999;155:411-419.
13. Voelkel NF, Taraseviciene-Stewart L, Cool C. Severe angioproliferative pulmonary hypertension: the lung circulation between vasoconstriction and cancer. Advances in Pulmonary Hypertension. 2003;4:4-8.
14. Heath D. Pulmonary hypertension in pulmonary parenchymal disease. Cardiovasc Clin 1972;4:79-96.
15. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(Suppl):13S-24S.
16. Bodolay E, Csipo I, Gal I, Sipka S, Gyimesi E, Szekanecz Z, Szegedi G. Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. Clin Exp Rheumatol 2004;22:409-415.
17. Negi VS, Tripathy NK, Misra R, Nityanand S. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 1998;25:462-466.
18. Renaudineau Y, Dugue C, Dueymes M, Youinou P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002;1:365-372.
19. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000;20:1-7.
20. Williams JM, Colman R, Brookes CJ, Savage CO, Harper L. Antiendothelial cell antibodies from lupus patients bind to apoptotic endothelial cells promoting macrophage phagocytosis but do not induce apoptosis. Rheumatology (Oxford) 2005;44:879-884.
21. Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, Wick G. In vivo analysis of the apoptosis-inducing effect of antiendothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 2003;48:2605-2614.
22. Quismorio FP Jr, Sharma O, Koss M, Boylen T, Edmiston AW, Thornton PJ, Tatter D. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13:349-359.
23. Nakagawa N, Osanai S, Ide H, Nishigaki Y, Takahashi S, Nakano H, Ohsaki Y, Kikuchi K, Tokusashi Y, Obata H. Severe pulmonary hypertension associated with primary Sjogren's syndrome. Intern Med 2003;42:1248-1252.
24. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15:427-438.
25. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 2005;19:1178-1180.
26. Oka M, Homma N, Taraseviciene-Stewart L, Morris K, Kraskauskas D, Voelkel NF, McMurtry I. Rho kinase-mediated vasoconstriction in severe obliterative arterial hypertension in rats [abstract]. Proc Am Thorac Soc 2006;3:A758.
27. Taraseviciene-Stewart L, Scerbavicius DK, Burns N, Cool CD, Nicolls MR, Voelkel NF. The protective role of T-lymphocytes in pulmonary vascular remodeling. Chest 2005;128:571S-572S.
28. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
29. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 1998;101:927-934.
30. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997;99:1313-1321.
31. Faul JL, Nishimura T, Berry GJ, Benson GV, Pearl RG, Kao PN. Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Am J Respir Crit Care Med 2000;162:2252-2258.
32. Miyata M, Sakuma F, Ito M, Ohira H, Sato Y, Kasukawa R. Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration. Int Arch Allergy Immunol 2000;121:246-252.
33. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.
34. Botstein GR, LeRoy EC. Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches. Am Heart J 1981;102:913-919.
35. Follansbee WP, Curtiss EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR, Rodnan GP. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984;310:142-148.
36. Tucker A, McMurtry IF, Alexander AF, Reeves JT, Grover RF. Lung mast cell density and distribution in chronically hypoxic animals J Appl Physiol 1977;42:174-178.
37. Kay JM, Waymire JC, Grover RF. Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats. Am J Physiol 1974;226:178-184.
38. Mitani Y, Ueda M, Maruyama K, Shimpo H, Kojima A, Matsumura M, Aoki K, Sakurai M. Mast cell chymase in pulmonary hypertension. Thorax 1999;54:88-90.
39. Heath D, Yacoub M. Lung mast cells in plexogenic pulmonary arteriopathy. J Clin Pathol 1991;44:1003-1006.
40. Heath D. Mast cells in the human lung at high altitude. Int J Biometeorol 1992;36:210-213.
41. Karulin AY, Hesse MD, Yip HC, Lehmann PV. Indirect IL-4 pathway in type 1 immunity. J Immunol 2002;168:545-553.
42. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142.
43. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002;420:875-878.
44. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-1692.
45. Valchanov KP, Proctor GB, Hartley RH, Paterson KL, Shori DK. Enzyme histochemistry of rat mast cell tryptase. Histochem J 1998;30:97-103.
46. Sherman MA. The role of STAT6 in mast cell IL-4 production. Immunol Rev 2001;179:48-56.
47. Erb KJ, Ruger B, von Brevern M, Ryffel B, Schimpl A, Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmunetype disorders in mice. J Exp Med 1997;185:329-339.
48. Chatila TA. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005;116:949-959. [Quiz, 960.]
49. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005;26:1110-1118.
50. Lan RY, Ansari AA, Lian ZX, Gershwin ME. Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005;4:351-363.
51. Perros F, Dorfmuller P, Souza R, Durand-Gasselin I, Mussot S, Mazmanian M, Herve P, Emilie D, Simonneau G, Humbert M. Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 2007;29:462-468.
52. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J 2002;19:571-576.
53. Jara LJ, Medina G, Vera-Lastra O, Amigo MC. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun Rev 2006;5:195-201.